Please assess the completion status of the following clinical trial:

Trial Title: A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~All patients age 18 years and older with typical trigeminal neuralgia, as determined by diagnostic criteria set by the International Headache Society, who are:~* Intolerant of or refractory to medical management; AND~* Not candidates for or refusing a surgical micro-vascular decompression.~Exclusion Criteria:~* Patients who present with pre-existing BNI grade III or IV facial numbness.~* Patients who have previously been treated with MVD.~* Patients who have previously had an ablative treatment, including prior SRS.~* Pediatric patients (age \<18), pregnant women, and patients who are unable to give informed consent will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo and SRS
- Amifostine (Type: EXPERIMENTAL): Amifostine and CyberKnife stereotactic radiosurgery

Based on this trial design, predict the completion outcome and termination type (if applicable).